Skip to main content
main-content

Free registration

Medicine Matters was developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

Detecting and treating JIA-associated uveitis

The recently published SHARE recommendations provide guidance on screening, diagnosis, and treatment for JIA-associated uveitis. medwireNews looks at the key features of the guidelines, and talks to specialists about the impact they will have.

22-03-2018 | Biosimilars | Editorial | Article

Biosimilars: The price is not right

Editorial Board member Marc Cohen analyzes the various economic factors influencing the price of biosimilars over recent years in rheumatology, focusing on the United States healthcare system.

15-05-2018 | Gout | News

‘Reassuring’ findings on fracture risk in patients with gout

Results of a large observational study suggest that patients with gout do not have an elevated risk for fragility fractures.

Latest from across the site

21-05-2018 | Article

Editorial board commentary

Author:
Victoria Ruffing

21-05-2018 | Pain | News

Recommendations issued for managing pain in patients with arthritis

EULAR has published recommendations for pain management in patients with inflammatory arthritis and osteoarthritis.

Source:

Ann Rheum Dis 2018; Advance online publication

18-05-2018 | Rheumatoid arthritis | News

HBV infection may compromise treatment response in patients with RA

Chronic hepatitis B virus infection is associated with poor response to treatment among patients with rheumatoid arthritis, study results suggest.

Source:

Arthritis Res Ther 2018; 20: 81

17-05-2018 | Rheumatoid arthritis | News

Durable response to sarilumab in patients with RA

Sarilumab has consistent safety and efficacy profiles over 2 years among patients with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate, results of an open-label extension study suggest.

Source:

Rheumatology 2018; Advance online publication

16-05-2018 | Juvenile idiopathic arthritis | News

Predictors of flare needed following etanercept withdrawal in JIA patients

A substantial proportion of patients with juvenile idiopathic arthritis who achieve clinical remission experience flares after stopping treatment with etanercept, and reliable predictors of flare are needed to help guide treatment decisions, say researchers.

Source:

J Rheumatol 2018; Advance online publication

15-05-2018 | Gout | News

‘Reassuring’ findings on fracture risk in patients with gout

Results of a large observational study suggest that patients with gout do not have an elevated risk for fragility fractures.

Source:

CMAJ 2018; 190: E581–E587

Meet our Editorial Board

New Content Item Meet our Advisory Board

image credits